The London-listed defense company said, however, that the U.S. government shutdown hasn’t yet had material effects on its U.S. business. Read more
Biztoc - Nov 12
Acquisition follows GSK’s 2021 decision to sell its antibiotics business for up to $500 million Read more
The Times - Oct 20
